Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants

1.4K

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.4K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.6K
Drug Dependence01:17

Drug Dependence

1.1K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.1K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

275
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
275
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

244
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
244
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cerebellar microRNA-206 tunes Purkinje neuron firing dynamics to control sensorimotor gating.

bioRxiv : the preprint server for biology·2026
Same author

Role of striatal dopamine signaling in compulsive eating associated with obesity.

Current opinion in behavioral sciences·2026
Same author

Gut-brain cholinergic signaling mediates the antiseizure effects of Bacteroides fragilis.

Neuron·2026
Same author

Crosstalk between alcohol use disorder and obesity: two sides of the same coin?

Molecular psychiatry·2025
Same author

Nicotine Reprograms Aging-Related Metabolism and Protects Against Motor Decline in Mice.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Leveraging single-cell spatial transcriptomics and connectomics to resolve brain circuit function in psychiatry.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2025

Related Experiment Video

Updated: Jul 20, 2025

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
14:21

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking

Published on: August 6, 2013

18.4K

New medications development for smoking cessation.

Dana Lengel1, Paul J Kenny1,2

  • 1Nash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Addiction Neuroscience
|July 31, 2023
PubMed
Summary

Nicotine dependence from tobacco use causes premature death. While smoking cessation aids help, new therapies targeting nicotine

More Related Videos

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

188
Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
06:39

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements

Published on: August 28, 2017

14.4K

Related Experiment Videos

Last Updated: Jul 20, 2025

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
14:21

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking

Published on: August 6, 2013

18.4K
Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

188
Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
06:39

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements

Published on: August 28, 2017

14.4K

Area of Science:

  • Neuroscience and Genetics of Nicotine Dependence
  • Pharmacology of Smoking Cessation

Background:

  • Tobacco use is a leading cause of preventable death in the United States.
  • Most smokers relapse shortly after attempting to quit, highlighting the limitations of current cessation methods.
  • Existing pharmacotherapies offer some benefit but fail to prevent relapse in a majority of individuals.

Purpose of the Study:

  • To review current advancements in understanding nicotine dependence.
  • To explore novel targets for developing more effective smoking cessation therapeutics.
  • To summarize ongoing efforts and future opportunities in smoking cessation drug development.

Main Methods:

  • Review of molecular, cellular, and systems-level research on nicotine's action in the brain.
  • Analysis of large-scale human genetics studies identifying genetic variants linked to tobacco use disorder.
  • Synthesis of current research on smoking cessation agents and therapeutic targets.

Main Results:

  • Significant progress has been made in understanding the neurobiological underpinnings of habitual tobacco use.
  • Human genetics studies have identified key genetic factors influencing susceptibility to nicotine dependence.
  • These discoveries provide a foundation for developing next-generation smoking cessation medications.

Conclusions:

  • Despite advances, current smoking cessation pharmacotherapy has limited efficacy in preventing relapse.
  • New therapeutic targets have emerged from recent neuroscience and genetics research.
  • Continued development of novel agents is crucial to improve long-term smoking abstinence rates.